Industry call: Maastricht Uni researchers hungry for satiety trial funding

By Shane Starling

- Last updated on GMT

'We have approached companies because we thought they would be interested in weight management but I am sure there will be many more.' ©iStock/OcusPocus
'We have approached companies because we thought they would be interested in weight management but I am sure there will be many more.' ©iStock/OcusPocus
Maastricht University researchers are seeking sponsors – preferably from a drink or shot maker – for a weight management trial exploring ‘intestinal brakes’ that has showed promising phase 1 results.

The trial used whey-encapsulated casein and sucrose supplied by Irish biotech firm AnaBio Technologies to deliver what is known as the ‘ileal brake’ – a negative feedback loop from the small intestine to the central nervous system that is provoked by the presence of undigested macronutrients in the ileum (small bowel).

Lead researcher Dr Henk Hendriks, from the Maastricht University Medical Centre in the Netherlands and Dutch private-public partnership the Top Institute for Food and Nutrition​, ​told us although the casein was the macronutrient used in the original trial, others like lipids could benefit from the AnaBio encapsulation technology and act as an ‘ileal brake’.

“We know from previous work that it doesn’t really matter if you encapsulate casein or a carbohydrate or a lipid,” ​Dr Hendriks said.

“The ‘phase 1’ trial found an appetite suppression effect but now we want to see if it will work if we do it for several days in a row and will people actually lose weight in the long term.”

“We have AnaBio on-board for the encapsulation but we are looking for sponsors, specifically companies that are designing real products. We’d prefer some kind of drink – that is a format that is easy to consume because you need to consume it before the meal – so a drink or a shot.”

“We have approached companies because we thought they would be interested in weight management but I am sure there will be many more.”

Study design

The previous study split 60 overweight 18-65 year olds (BMI – Body Mass Index – between 25-30) into two groups and found the study group who consumed an encapsulated casein drink three hours after breakfast had reduced appetites compared to placebo.

Henk-Hendriks-MaastrichtUni
Dr Henk Hendriks

Dr Hendriks said the unpublished results showed food intake reduced; satiety increased and there was no early plasma glucose peak after oral intake of encapsulated nutrients.

“The question arises whether after repeated delivery of encapsulated nutrients the same magnitude of inhibitory effect on meal intake is sustained: chronic vs acute interventions.”

Related news

Show more

Related products

show more

13X Boost in Glutathione with LipoAvail™

13X Boost in Glutathione with LipoAvail™

Content provided by Effepharm Ltd | 18-Sep-2024 | Product Brochure

Glutathione is a powerful antioxidant and vital metabolic regulator within cells. But it is unstable, susceptible to light, humidity, heat, gastric acid,...

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 09-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group | 05-Sep-2024 | Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of...

Related suppliers

Follow us

Products

View more

Webinars